Session Title:?Change Your Genes, Change Your Life: Creating Optimal Health with the New Science of Epigenetics?
Kenneth R. Pelletier, PhD, MD ? holds a unique joint faculty appointment as a Clinical Professor of Medicine, Department of Medicine; Department of Family and Community Medicine; and Department of Psychiatry at the University of California School of Medicine (UCSF) in San Francisco; and, also as a Professor of Public Health in the UCLA Fielding School of Public Health (FSOPH). At UCLA, he is Director of the Corporate Health Improvement Program (CHIP) which is a collaborative research program between CHIP and 15 of the Fortune 500 corporations including Ford, Oracle, Prudential, Dow, Lockheed Martin, NASA, Pepsico, IBM, Cummins, Steelcase, and the Mayo Clinic. He also serves as Chairman of the American Health Association (AHA) and is a Vice President with American Specialty Health (ASH).
Prior to these positions, from 2001 to 2016, Dr. Pelletier served as Clinical Professor of Medicine in the Department of Medicine, the Department of Family and Community Medicine, as well as a Professor of Public Health, at the University of Arizona School of Medicine. From 1990 through 2001, Dr. Pelletier was a Clinical Professor of Medicine at the Stanford University School of Medicine; was Director of the Stanford Corporate Health Improvement Program (SCHIP); and, Director of the NIH funded Complementary and Alternative Medicine Program at Stanford (CAMPS). From 1974 until joining the Stanford University School of Medicine in 1990, Dr. Pelletier held a dual appointment as an Associate Clinical Professor in the Department of Medicine and in the Department of Psychiatry, University of California School of Medicine (UCSF) in San Francisco. In addition to his faculty positions, Dr. Pelletier has served as a member of the Board of Directors and Chairman of the California Wellness Foundation, Foundation Health Systems (FHS), Health Systems International (HSI), and the Social Venture Network. He was a Woodrow Wilson Fellow, studied at the CG Jung Institute in Zurich, Switzerland and has published over 300 professional journal articles in behavioral medicine, disease management, worksite interventions, alternative/ integrative medicine, and epigenetics.
At the present time, Dr. Pelletier is a medical and business consultant to the US Department of Health and Human Services, the World Health Organization (WHO), the National Business Group on Health, the Federation of State Medical Boards, and major corporations including Cisco, IBM, American Airlines, Prudential, Dow, Disney, Ford, Mercer, Merck, Pepsico, Ford, Pfizer, Walgreens, NASA, Microsoft ENCARTA, Blue Cross/Blue Shield, United Healthcare, Health Net, the Pasteur Institute of Lille, France, the Alpha Group of Mexico, and the Singapore Ministry of Health. He also serves on the boards of the Rancho la Puerta (Mexico), Fries Foundation, American Institute of Stress (AIS), American Journal of Health Promotion (AJHP), as a Founding Board Member of the American Board of Integrative Medicine (ABOIM), and as a peer reviewer for the Journal of the American Medical Association (JAMA), the Journal of Occupational and Environmental Medicine (JOEM), Annals of Internal Medicine, Health Affairs, and webMD.